{"pmid":32396446,"title":"Otologic and Audiologic Considerations for COVID-19.","text":["Otologic and Audiologic Considerations for COVID-19.","The COVID-19 pandemic has created a number of considerations for otolaryngology; anosmia and ageusia in particular have gained significant attention. Here we present considerations in regard to treatment with quinine-derived drugs and the influence of masks on communication.","Otolaryngol Head Neck Surg","Eby, Thomas L","Arteaga, Alberto A","Spankovich, Christopher","32396446"],"abstract":["The COVID-19 pandemic has created a number of considerations for otolaryngology; anosmia and ageusia in particular have gained significant attention. Here we present considerations in regard to treatment with quinine-derived drugs and the influence of masks on communication."],"journal":"Otolaryngol Head Neck Surg","authors":["Eby, Thomas L","Arteaga, Alberto A","Spankovich, Christopher"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32396446","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1177/0194599820928989","keywords":["covid-19","audiology","chloroquine","communication","hydroxychloroquine","otology"],"topics":["Prevention"],"weight":1,"_version_":1666627827974275073,"score":9.490897,"similar":[{"pmid":32286916,"title":"A Commentary on Safety Precautions for Otologic Surgery during the COVID-19 Pandemic.","text":["A Commentary on Safety Precautions for Otologic Surgery during the COVID-19 Pandemic.","There are insufficient data regarding the safety of otologic procedures in the setting of the coronavirus disease 2019 (COVID-19) pandemic. Given the proclivity for respiratory pathogens to involve the middle ear and the significant aerosolization associated with many otologic procedures, safety precautions should follow current recommendations for procedures involving the upper airway. Until preoperative diagnostic testing becomes standardized and readily available, elective cases should be deferred and emergent/urgent cases should be treated as high risk for COVID-19 exposure. Necessary otologic procedures on positive, suspected, or unknown COVID-19 status patients should be performed using enhanced personal protective equipment, including an N95 respirator and eye protection or powered air-purifying respirator (PAPR, preferred), disposable cap, disposable gown, and gloves. Powered instrumentation should be avoided unless absolutely necessary, and if performed, PAPR or sealed eye protection is recommended.","Otolaryngol Head Neck Surg","Saadi, Robert A","Bann, Darrin V","Patel, Vijay A","Goldenberg, David","May, Jason","Isildak, Huseyin","32286916"],"abstract":["There are insufficient data regarding the safety of otologic procedures in the setting of the coronavirus disease 2019 (COVID-19) pandemic. Given the proclivity for respiratory pathogens to involve the middle ear and the significant aerosolization associated with many otologic procedures, safety precautions should follow current recommendations for procedures involving the upper airway. Until preoperative diagnostic testing becomes standardized and readily available, elective cases should be deferred and emergent/urgent cases should be treated as high risk for COVID-19 exposure. Necessary otologic procedures on positive, suspected, or unknown COVID-19 status patients should be performed using enhanced personal protective equipment, including an N95 respirator and eye protection or powered air-purifying respirator (PAPR, preferred), disposable cap, disposable gown, and gloves. Powered instrumentation should be avoided unless absolutely necessary, and if performed, PAPR or sealed eye protection is recommended."],"journal":"Otolaryngol Head Neck Surg","authors":["Saadi, Robert A","Bann, Darrin V","Patel, Vijay A","Goldenberg, David","May, Jason","Isildak, Huseyin"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32286916","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1177/0194599820919741","keywords":["covid-19","coronavirus","exposure","otology","safety precautions"],"topics":["Prevention"],"weight":1,"_version_":1666138491348582402,"score":128.22487},{"pmid":32373183,"pmcid":"PMC7192209","title":"Chloroquine and hydroxychloroquine in the context of COVID-19.","text":["Chloroquine and hydroxychloroquine in the context of COVID-19.","Chloroquine and closely related structural analogs, employed initially for the treatment of malaria, are now gaining worldwide attention due to the rapidly spreading pandemic caused by severe acute respiratory syndrome-coronavirus-2, named coronavirus disease (COVID) of 2019 (COVID-19). Although much of this attention has a mechanistic basis, the hard efficacy data for chloroquine/hydroxychloroquine in the management of the clinical syndrome of COVID-19 have been limited thus far. This review aims to present the available in vitro and clinical data for the role of chloroquine/hydroxychloroquine in COVID-19 and attempts to put them into perspective, especially in relation to the different risks/benefits particular to each patient who may require treatment.","Drugs Context","Shukla, Ashutosh M","Archibald, Lennox K","Shukla, Aparna Wagle","Mehta, Hiren J","Cherabuddi, Kartikeya","32373183"],"abstract":["Chloroquine and closely related structural analogs, employed initially for the treatment of malaria, are now gaining worldwide attention due to the rapidly spreading pandemic caused by severe acute respiratory syndrome-coronavirus-2, named coronavirus disease (COVID) of 2019 (COVID-19). Although much of this attention has a mechanistic basis, the hard efficacy data for chloroquine/hydroxychloroquine in the management of the clinical syndrome of COVID-19 have been limited thus far. This review aims to present the available in vitro and clinical data for the role of chloroquine/hydroxychloroquine in COVID-19 and attempts to put them into perspective, especially in relation to the different risks/benefits particular to each patient who may require treatment."],"journal":"Drugs Context","authors":["Shukla, Ashutosh M","Archibald, Lennox K","Shukla, Aparna Wagle","Mehta, Hiren J","Cherabuddi, Kartikeya"],"date":"2020-05-07T11:00:00Z","year":2020,"_id":"32373183","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.7573/dic.2020-4-5","keywords":["covid-19","sars-cov-2","anti-inflammatory","antimalarial","antiviral","chloroquine","hydroxychloroquine","immunomodulatory","pandemic"],"e_drugs":["Hydroxychloroquine","Chloroquine"],"topics":["Treatment"],"weight":1,"_version_":1666138496345047040,"score":89.141335},{"pmid":32366178,"title":"Defining Essential Services for Deaf and Hard of Hearing Children during the COVID-19 Pandemic.","text":["Defining Essential Services for Deaf and Hard of Hearing Children during the COVID-19 Pandemic.","COVID-19 is a rapidly growing global pandemic caused by a novel coronavirus. With no vaccine or definitive treatment, public health authorities have recommended a strategy of \"social distancing,\" reducing individual interaction, canceling elective procedures, and limiting nonessential services. Health care providers must determine what procedures are considered \"elective,\" balancing risk of treatment delays with that of coronavirus exposure to patient, family, and providers. Given critical periods for language development and the long-term impact of auditory deprivation, some audiologic and otologic services should be considered essential. In this article, we describe the experience of a quaternary referral pediatric hospital in Seattle, the epicenter of COVID-19 in the United States, and share strategies for risk minimization employed by Seattle Children's Hospital. We hope that this work can be a reference for other centers continuing care for children who are deaf and hard of hearing during the COVID-19 and future resource-limiting crises.","Otolaryngol Head Neck Surg","Pattisapu, Prasanth","Evans, Sean S","Noble, Anisha R","Norton, Susan J","Ou, Henry C","Sie, Kathleen C Y","Horn, David L","32366178"],"abstract":["COVID-19 is a rapidly growing global pandemic caused by a novel coronavirus. With no vaccine or definitive treatment, public health authorities have recommended a strategy of \"social distancing,\" reducing individual interaction, canceling elective procedures, and limiting nonessential services. Health care providers must determine what procedures are considered \"elective,\" balancing risk of treatment delays with that of coronavirus exposure to patient, family, and providers. Given critical periods for language development and the long-term impact of auditory deprivation, some audiologic and otologic services should be considered essential. In this article, we describe the experience of a quaternary referral pediatric hospital in Seattle, the epicenter of COVID-19 in the United States, and share strategies for risk minimization employed by Seattle Children's Hospital. We hope that this work can be a reference for other centers continuing care for children who are deaf and hard of hearing during the COVID-19 and future resource-limiting crises."],"journal":"Otolaryngol Head Neck Surg","authors":["Pattisapu, Prasanth","Evans, Sean S","Noble, Anisha R","Norton, Susan J","Ou, Henry C","Sie, Kathleen C Y","Horn, David L"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32366178","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1177/0194599820925058","keywords":["covid-19","audiology","hearing loss","pandemic","pediatric otolaryngology"],"locations":["Seattle","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666138496225509376,"score":87.83444},{"pmid":32340539,"title":"Otolaryngology Education in the Setting of COVID-19: Current and Future Implications.","text":["Otolaryngology Education in the Setting of COVID-19: Current and Future Implications.","The COVID-19 pandemic continues to garner extensive international attention. The pandemic has resulted in significant changes in clinical practice for otolaryngologists in the United States; many changes have been implemented to mitigate risks identified by otolaryngologists in other countries. COVID-19-induced limitations include social distancing and triaging of patient acuity. Additionally, a recent publication by Stanford University has drawn attention to the risks that otolaryngologists may face with regard to manipulation of the upper airway and mucosal disruption. As a result of COVID-19 recommendations, multiple institutions have overhauled resident clinical rotations and resident education. The result has been a rapid and significant change in resident education at most academic institutions. This commentary outlines the development of the otolaryngology resident education consortiums, with implications for future education within and outside of otolaryngology.","Otolaryngol Head Neck Surg","Comer, Brett T","Gupta, Nikita","Mowry, Sarah E","Malekzadeh, Sonya","32340539"],"abstract":["The COVID-19 pandemic continues to garner extensive international attention. The pandemic has resulted in significant changes in clinical practice for otolaryngologists in the United States; many changes have been implemented to mitigate risks identified by otolaryngologists in other countries. COVID-19-induced limitations include social distancing and triaging of patient acuity. Additionally, a recent publication by Stanford University has drawn attention to the risks that otolaryngologists may face with regard to manipulation of the upper airway and mucosal disruption. As a result of COVID-19 recommendations, multiple institutions have overhauled resident clinical rotations and resident education. The result has been a rapid and significant change in resident education at most academic institutions. This commentary outlines the development of the otolaryngology resident education consortiums, with implications for future education within and outside of otolaryngology."],"journal":"Otolaryngol Head Neck Surg","authors":["Comer, Brett T","Gupta, Nikita","Mowry, Sarah E","Malekzadeh, Sonya"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32340539","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1177/0194599820923621","keywords":["consortium","otolaryngology","remote learning","resident education"],"locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666138495110873088,"score":87.64029},{"pmid":32281583,"title":"Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).","text":["Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).","Drugs that are specifically efficacious against SARS-CoV-2 have yet to be established. Chloroquine and hydroxychloroquine have garnered considerable attention for their potential to treat coronavirus disease 2019 (COVID-19). Increasing evidence obtained from completed clinical studies indicates the prospects for chloroquine/hydroxychloroquine to treat COVID-19. More randomized control clinical studies are warranted to determine the feasibility of these two drugs in treating COVID-19.","Biosci Trends","Gao, Jianjun","Hu, Shasha","32281583"],"abstract":["Drugs that are specifically efficacious against SARS-CoV-2 have yet to be established. Chloroquine and hydroxychloroquine have garnered considerable attention for their potential to treat coronavirus disease 2019 (COVID-19). Increasing evidence obtained from completed clinical studies indicates the prospects for chloroquine/hydroxychloroquine to treat COVID-19. More randomized control clinical studies are warranted to determine the feasibility of these two drugs in treating COVID-19."],"journal":"Biosci Trends","authors":["Gao, Jianjun","Hu, Shasha"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32281583","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.5582/bst.2020.03072","keywords":["covid-19","sars-cov-2","chloroquine","hydroxychloroquine"],"e_drugs":["Hydroxychloroquine","Chloroquine"],"topics":["Treatment"],"weight":1,"_version_":1666138491416739841,"score":83.583466}]}